Bio plays are getting crushed across the board. GERN's time will come, but with a June approval date, expeacting a run-up at this time is a bit over optimistic IMO.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.